Addressing Adverse Reactions: Strategies for BCG Treatment Optimization

16 Aug 2025 10:45 11:00
Marinelle DoctorAustralia Speaker Addressing Adverse Reactions: Strategies for BCG Treatment OptimizationIntravesical Bacillus Calmette-Guerin BCG Therapy has been a cornerstone in the management of non-muscle invasive bladder cancer for several decades, demonstrating efficacy in reducing recurrence and progression rates. Nonetheless,its application is frequently limited by adverse reactions experienced by patients. These reactions, ranging from mild local irritations to severe systemic manifestations, pose significant challenges to both clinicians and patients, potentially leading to treatment discontinuation and compromised therapeutic outcomes.This session aims to explore innovative strategies for optimizing BCG treatments by mitigating these side effects. In addition to clinical approaches, this session will highlight recent advancements in predictive markers for susceptibility to adverse reactions, offering insights into tailoring individual treatment plans.Furthermore, this session will tackle the impact of psychological support in managing treatment-related side effects. Participants attending this session will gain deeper understanding on how to enhance patient experience, improve compliance with BCG therapy , and ultimately achieve better therapeutic outcomes in bladder cancer treatment.